Anti-B12 molecules have been synthesized with an “upper” axial substituent, that is inert to the Cbl-reducing enzyme methylmalonic aciduria and homocystinuria type C protein (CblC) [17, 24, 25]. Here, CBL is linked to Methylmalonic aciduria.